Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stereotactic body radiotherapy (SBRT)].

Yasushi Nagata1, Kenji Takayama, Yukinori Matsuo

  • 1Dept. of Radiation Oncology, Kyoto University Graduate School of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring using a gimbal-mounted linac for liver tumors: a multicenter observational study.

International journal of clinical oncology·2025
Same author

Multi-Institutional Phase II Study on the Efficacy and Safety of Dynamic Tumor-Tracking, Moderately Hypofractionated Intensity-Modulated Radiotherapy in Patients With Locally Advanced Pancreatic Cancer.

Cancer medicine·2025
Same author

Highly hypofractionated biaxially rotational dynamic radiation therapy (BROAD-RT) for high-risk prostate cancer.

Cancer science·2025
Same author

Optimal Duration of Consolidation Durvalumab Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer: A Multi-institutional Retrospective Study.

Targeted oncology·2024
Same author

Cost-Utility Analysis of Stereotactic Body Radiation Therapy Versus Surgery for Patients With Stage I Non-small Cell Lung Cancer in Japan.

International journal of radiation oncology, biology, physics·2024
Same author

Prospective external validation of radiomics-based predictive model of distant metastasis after dynamic tumor tracking stereotactic body radiation therapy in patients with non-small-cell lung cancer: A multi-institutional analysis.

Journal of applied clinical medical physics·2024

Stereotactic body radiotherapy (SRT) offers a promising non-invasive treatment for early-stage lung cancer. This technique uses high doses of radiation to target tumors precisely, achieving over 90% local control with minimal complications.

Area of Science:

  • Radiation Oncology
  • Medical Physics

Context:

  • Advancements in three-dimensional conformal radiotherapy (3D-CRT) and patient immobilization techniques.
  • Need for improved local control in radiotherapy for solitary lung tumors.

Purpose:

  • To evaluate the efficacy and safety of stereotactic body radiotherapy (SRT) for early-stage lung cancer.
  • To assess the potential of high-dose, focused radiation delivery for solitary lung tumors.

Summary:

  • Stereotactic body radiotherapy (SRT) utilizes 3D-CRT to deliver high radiation doses (10-15 Gy per fraction) over 3-5 sessions.
  • Clinical studies report local control rates exceeding 90% with very low complication rates.
  • This non-invasive approach shows promise for treating early-stage lung cancer.

Related Experiment Videos

Impact:

  • SRT represents a significant advancement in non-invasive lung cancer treatment.
  • High local control rates and low toxicity suggest SRT as a viable alternative to conventional therapies.
  • Ongoing multi-institutional studies like JCOG 0403 are further validating SRT's role in clinical practice.